TRCT
ONCR

Tower Research Capital (TRC)’s Oncorus, Inc. ONCR Stock Holding History

Tower Research Capital (TRC)’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-8,581
Closed -$3K – 6525
2023
Q1 		$3K Sell
8,581
-21
-0.2% -$8 ﹤0.01% 5289
2022
Q4 		$2K Sell
8,602
-2,555
-23% -$1.45K ﹤0.01% 5496
2022
Q3 		$9K Buy
11,157
+2,855
+34% +$3.66K ﹤0.01% 4736
2022
Q2 		$10K Buy
8,302
+1,504
+22% +$2.04K ﹤0.01% 4514
2022
Q1 		$12K Sell
6,798
-5,136
-43% -$14.4K ﹤0.01% 4123
2021
Q4 		$63K Buy
11,934
+2,949
+33% +$22.8K ﹤0.01% 2587
2021
Q3 		$84K Buy
8,985
+6,906
+332% +$78.8K ﹤0.01% 2543
2021
Q2 		$29K Buy
2,079
+987
+90% +$15.2K ﹤0.01% 3548
2021
Q1 		$15K Buy
1,092
+933
+587% +$19.3K ﹤0.01% 4133
2020
Q4 		$5K Buy
+159
New +$3.68K ﹤0.01% 4662

Other funds holding ONCR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
YAL
Your Advocates Ltd Houston, Texas $350M AUM 21.03% 1-Year Est. Return

Tower Research Capital (TRC)'s ONCR Position: Q2 2023 in Review

Tower Research Capital (TRC) sold out of Oncorus, Inc. (ONCR) in Q2 2023, closing a stake of 8,581 shares — an estimated $3K sold.

Tower Research Capital (TRC) first reported a position in ONCR in Q4 2020 and held it in 10 quarters. The position peaked at $84K in Q3 2021. 4 funds tracked by Wall St. Rank hold ONCR as of Q2 2023.

  • Tower Research Capital (TRC) reported no remaining Oncorus, Inc. position as of Q2 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 8,581 Oncorus, Inc. shares in Q2 2023, an estimated $3K.
  • Tower Research Capital (TRC) first reported a position in Oncorus, Inc. in Q4 2020 and held it in 10 quarters.
  • Tower Research Capital (TRC)'s Oncorus, Inc. position peaked at $84K in Q3 2021.
  • 4 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q2 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.